filmov
tv
Dyno Therapeutics
Показать описание
Eric Kelsic, Ph.D., CEO
Cambridge, MA
(Private)
Dyno Therapeutics creates novel adeno-associated virus (AAV) vectors that enable safe, efficient and targeted in-vivo delivery for revolutionary gene and genome editing therapies. The company’s data-driven approach combines next generation DNA synthesis of millions of AAV capsids with high throughput sequencing and machine learning. The company is systematically mapping the relationship between capsid sequence and function to optimize AAV capsids for improved therapeutic efficacy, in partnership with clinical and preclinical stage companies.
Cambridge, MA
(Private)
Dyno Therapeutics creates novel adeno-associated virus (AAV) vectors that enable safe, efficient and targeted in-vivo delivery for revolutionary gene and genome editing therapies. The company’s data-driven approach combines next generation DNA synthesis of millions of AAV capsids with high throughput sequencing and machine learning. The company is systematically mapping the relationship between capsid sequence and function to optimize AAV capsids for improved therapeutic efficacy, in partnership with clinical and preclinical stage companies.
0:09:46
0:23:10
1:42:15
0:12:41
1:26:49
0:19:37
1:10:49
1:42:15
0:19:37
0:24:14
0:05:31
0:01:51
0:00:55
0:41:33
0:01:32
0:01:22
1:00:04
0:16:31
0:00:35
1:42:15
0:16:10
1:36:47
0:00:40
1:06:10